7th Belgian scientific Stroke Workshop
SAVE THE DATE
The 7th Belgian Scientific Stroke Workshop will be held this year at Ziekenhuis Oost-Limburg on 20th September.
Visit the scientific stroke workshop page for more information
Prevent, Treat and Support: a manifesto for stroke survivors
The Stroke Alliance for Stroke ( SAFE) and the European Stroke Organisation (ESO) have published a manifesto outlining a number of keypoints to improve prevention, treatment and support for stroke patients across Europe. In the meantime, a letter has been sent to all Belgian members of the European Parliament and Belgian ministers of health, asking them to consider including these initiatives in their electoral programs. Read the manifesto here and the letter sent to our ministers here
BSC Applauds Initial Step in Stroke Care Structuring but Calls for Uniform Criteria Across Regions
On 23 May 2024, the BSC published a press release applauding the recognition of Belgian S2 centres, but calling for uniform certification criteria across the country. Read it here
Remboursement Xarelto 2,5 mg
We are delighted to announce that neurologists also have been recognised for the reimbursement of Xarelto 2.5mg in coronary artery disease (CAD) and peripheral artery disease PAD), since February 1, 2024.
Furthermore, the duration of acceptance has been changed, since the 3-year limit has been withdrawn.
Please find attached Bayer’s information letter: BE.XAR.VAE_Remboursement CADPAD_FR
2023 Symposium minutes
Symposium is closed…
… but it still time to check the summary, the short presentations the speakers made and to have a look at the pictures of the day !
Actilyse vials with latex plugs that could also contain traces of Gentamycine.
Dear members of the SB,
As part of the strategy to resolve the worldwide shortage of thrombolytic therapy, the BSC has been informed that Boehringer-Ingelheim will temporarily produce Actilyse vials with latex plugs that could also contain traces of Gentamycine. These vials could be encountered in your local hospital from the end of October onward (and will likely be produced for several months).
BI states that boxes containing vials with latex plugs and vials that could contain traces of Gentamycine will be clearly labeled by stickers (see photograph). These vials should never be administered to patients with a latex/rubber sensitivity or sensitivity to Gentamycine.
